The Amyloidoses Douglas A. Stahura 4/7/99.

Slides:



Advertisements
Similar presentations
Eleventh International Symposium HEART FAILURE & Co. MORTE IMPROVVISA SUDDEN DEATH Reggia di Caserta, aprile 2011 Lamiloidosi: il danno cardiaco.
Advertisements

Echocardiography of Cardiac Amyloidosis
Hyaline change It is a change in the physical appearance of the tissues which become homogenous, glossy, translucent and pink with H&E staining There is.
Amyloidosis Fibrinoid, Hyalin General Pathology Jaroslava Dušková
2nd Year Pathology 2010 Extracellular Pathology Amyloidosis Pathological calcification Pathological calcification Ageing Ageing.
Amyloidosis Definition : In medicine, amyloidosis refers to a variety of conditions in which amyloid proteins are abnormally deposited in organs causing.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Primary Myocardial Disease Dr. Raid Jastania. Case.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub- intern under Nephrology Division, Department of Medicine in King Saud University.
Waldenstrom’s Macroglobulinemia
CONGENITAL ABNORMALITIES OF M/S SYSTEM Developmental dysplasia of hip Scoliosis.
Amyloidosis for the young ladies. Amyloidosis Definition : In medicine, amyloidosis refers to a variety of conditions in which amyloid proteins are abnormally.
Ann Isaksen Morning Report November 10, 2009
QUIZ OF THE WEEK By .. Shada AlGhamdi.
Protein Misfolding: Therapeutic Implications
Amyloidosis Dr Hisham Alkhalidi. AMYLOIDOSIS Amyloid is a pathologic proteinaceous substance, deposited between cells in various tissues and organs of.
Amyloidosis Dr. Amitabha Basu.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Recent SPECT/CT Imaging Studies using ORNL/JLAB instrumentation Bethesda May 20, 2005.
Rheumatic Fever. Rheumatic fever is an inflammatory disease that may develop after an infection with Streptococcus bacteria (such as strep throat or scarlet.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Case Discussion Dr. Raid Jastania. What is the outcome of inflammation?
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
SEVERE DISSEMINATED CUTANEOUS GOUT -CASE REPORT- Irina Tudose1, Olguta Anca Orzan2, Diana Petrache2, Prof. Dr. Calin Giurcaneanu2 1 Pathology Department,
Rheumatoid Arthritis By: Marina McAninch.
Theme 2 MESENCHYMAL DYSTROPHY.
AMYLOIDOSIS 소화기 내과 R3 박지영. Amyloidosis  Amyloid Cellulose-like deposits Virchow in 1854 Positive birefringence with polarized light  Biochemical nature.
The Neuromuscular Manifestations of Amyloidosis
Pathologic Diagnosis in Amyloidosis
Immune Disorders: HLA and Disease Associations and Amyloidosis
Senior Talk Collins Okolie PGY3
Amyloidosis By:Dental Tutotr.. Amyloidosis Extracellular deposition of fibrillar proteinaceous substance called amyloid – a ‘ waxy substance ’ composed.
Paraproteinaemias. Multiple myeloma. Amyloidosis. Part 2 Dr
Rheumatic Diseases “Arthritis”
III. Endocrine Pancreas Diabetes Mellitus
IMMUNOPATHOLOGY DR.MAYSEM LEC.4.
AMYLOIDOSIS. Extra cellular deposition of fibrillar proteinaceous substance; amyloid. Misnomer= meaning starch-like; Affected organs C/S stained brown.
A. Karki1, V. Patel2, K. Sherani3,J. Raynor3, K. Mandal3, A. Shalonov3 
CPPD DEPOSITION DISEASE
AMYLOIDOSIS III HA MWAKYOMA, MD.
Amyloidosis.
Dr Vishal Saxena MBBS,MD(Path),FICMR
Diseases of the Immune System
ILOs of the fourth lecture
THE “UNDER-LINING” CAUSE OF RIGHT HEART FAILURE AFTER CARDIAC SURGERY
Nat. Rev. Nephrol. doi: /nrneph
Parasitic Kidney Disease: Milestones in the Evolution of Our Knowledge
Myeloma-related Kidney Disease
Amyloidosis.
65 year-old female who collapsed at home
The Prevalence and Management of Systemic Amyloidosis in Western Countries Kidney Dis 2016;2: DOI: / Fig. 1. A subcutaneous abdominal.
Globular amyloidosis Case 15.1 Chapter 15 1
AG10-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of AG10 versus Placebo in ATTR-CM Background Primary Endpoints Key Exclusion Criteria.
How to Find Relief & Reduce Flare-Ups
Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the Literature  MORIE A. GERTZ, M.D., ROBERT A. KYLE,
Christophe Sirac, Frank Bridoux  Kidney International 
Familial Mediterranean Fever
AMYLOID AND AF: WHAT ARE WE MISSING?
AJKD Atlas of Renal Pathology: Hereditary and Other Non-AL Amyloidoses
Volume 77, Issue 9, Pages (May 2010)
Reversible Restrictive Cardiomyopathy Due to Light-Chain Deposition Disease  Motoyuki Nakamura, MD, Mamoru Satoh, MD, Shugo Kowada, MD, Hidetoshi Satoh,
Volume 134, Issue 2, Pages (August 2008)
Dustin G. James, Gary R. Zuckerman, Gregory S. Sayuk, Hanlin L
Emerging treatments for amyloidosis
New Clinical Insights Into the Pathology of Amyloidosis
Homozygous Transthyretin Mutation in an African American Male
Unusual Biopsy Findings in a Hepatitis C–Infected White Man With Cryoglobulinemia, Purpuric Rash, and Renal Failure  Sumit Mohan, MBBS, MPH, Manasvi Jaitly,
Leukocyte chemotactic factor 2: A novel renal amyloid protein
Amyloid American Journal of Kidney Diseases
Presentation transcript:

The Amyloidoses Douglas A. Stahura 4/7/99

Amyloidoses History Virchow described a homogenous eosinophilic material which binds Congo red stain. Associated with inflammatory joint disease and amyloid deposition in kidney, liver, spleen.

Amyloidoses Definition Criteria for definition Homogenous, hyaline eosinophilic on H+E stain Crystal violet metachromasia Stains with alkaline Congo red Apple green birefringence on polarized light Fibrillar structure on microscopy Salt extraction yields p-component forms Fibril is unique for all forms of amyloid

Amyloidoses AL L-chain primary, MM AH H-chain primary, MM ATTR transthyretin senile systemic Abeta2M Beta2 microglobulin dialysis Abeta beta-protein precursor Alzheimer Ascr Scrapie Creutzfeldt-Jakob

Amyloidoses Most common clinical form beta protein placque of Alzheimer’s for rheumatoligist AL disease primary amyloidoses or MM

Amyloidoses Clinical Presentation Renal: nephrotic range protenuria or mild must be distinguished from monoclonal light chains protein may diminish with renal insufficiency HTN Enlargement occurs early

Amyloidoses Clinical Presentation Cardiac: Restrictive cardiomyopathy- noncompliant hemodynamics, thickening of septum on Echo- “sparkling” of echoes endomyocardial biopsy shows AL deposition on immunohistochemical staining Digoxin and Nifedipine toxicity reported due to collective binding to fibrils.

Amyloidoses Complication AL disease - acquired deficiency of clotting factor X Periarticular amyloid deposition presenting as pseudoarthritis = shoulder pad sign

Amyloidoses Treatment Melphalan and Prednisone 2 controlled trials with no statiscally significant improvement in survival 20% of patients did have improvement

Amyloidoses B2 Microglobulinemia significant articular presentation with chronic renal disease all reported pt’s presented with joint pain carpal tunnel osteonecrosis dialysis for mean of 7 years B2 microglobulin is polypeptide of class I protein of MHC

Amyloidoses AA Amyloid AA deposition in tissues, associated with rheumatoid arthritis familial Mediterranean fever Recent series 5% of RA have tissue deposits and 2% have cinically evident disease, usually renal or hepatic. Worldwide, AA deposition common in leprosy, tuberculosis, osteomyelitis.

Amyloidoses AA Amyoid Clinical - episodic fever, arthritis, abdominal/pleuritic inflammation Treatment - Colchicine abortive of acute episodes abortive of amyloid formation

Amyloidoses Aging 5 sites identified with aging Brain: beta protein of Alzheimer’s Pancreas: islet associated polypeptide ANF: fibril of isolated atrial amyloid Cardiac: transthyretin, senile systemic amyloid Aorta: fibril not identified